
Findings increasingly suggest the mortality risk may be reduced by initiating daptomycin within 3 days of infection.
Fidelia Bernice, PharmD, BCIDP, is an infectious diseases clinical pharmacist at the University of Maryland Medical Center in Baltimore.
Findings increasingly suggest the mortality risk may be reduced by initiating daptomycin within 3 days of infection.